<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02577133</url>
  </required_header>
  <id_info>
    <org_study_id>HGNAE-04</org_study_id>
    <nct_id>NCT02577133</nct_id>
  </id_info>
  <brief_title>Prevention of Colic With the Probiotic Lactobacillus Reuteri</brief_title>
  <official_title>Prevention of Colic With the Probiotic Lactobacillus Reuteri in Mexican Infants: Randomized, Double-blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General Naval de Alta Especialidad - Escuela Medico Naval</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General Naval de Alta Especialidad - Escuela Medico Naval</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Colic is a term for inconsolable crying happened in the first months of life. Its etiology is
      multifactorial and caregiver and pediatrician generates among other problems: anxiety, risk
      of child abuse as well as economic costs.

      There is now enough evidence for the treatment of colic using probiotics, especially
      Lactobacillus reuteri.

      The investigators study aims to demonstrate the utility for the prevention of colic with L.
      reuteri and thereby avoid the problems caused by this pathology.

      Objective: Compare the number of events of colic among infants with oral probiotic
      Lactobacillus reuteri during the first month of life versus infants with placebo

      Study Design. Double blind, randomized, controlled, 492 neonates of 37-42 gestational age,
      breast or formula fed, will receive L. reuteri 5 drops (1x108 CFU) daily or placebo for 28
      days. The investigators trial will be performed at Naval Hospital in Mexico City.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods:

      This study is planned for October 2015 to October 2016 aiming newborns born population in
      Naval Hospital

      Inclusion:

        -  Term Healthy Newborns (RN) ≥38 weeks and ≤ 41 weeks of gestation

        -  Appropriate weight for gestational age

        -  ≥than 8 Apgar at 5 minutes

        -  Egress at the first 24-48 hours of life of the newborn with the mother of hospital

        -  No congenital or physical abnormalities on physical examination at birth.

        -  Availability during the study period.

        -  Thorough understanding of the protocol by parents

        -  Informed Consent is signed by both parents.

      Exclusion:

        -  Administration of antibiotics to the mother for a week before the birth of the newborn.

        -  Administration of probiotics newborn before inclusion or consumption by the mother
           during these last two trimesters.

        -  Medication Management newborn different routine prescribed at birth.

      Elimination

        -  Loss of monitoring

        -  Abandonment by parents

        -  Diagnosis of allergy to cow's milk protein (confirmed by resolution of symptoms after
           switching to Formula hypo allergenic or free feeding cow's milk by the mother in
           breastfed children).

        -  Diagnosis of structural alterations or gastrointestinal illness to explain the symptoms
           of colic in the following months after the inclusion

      Interventions:

      The patients enrolled will receive probiotics (1000000000 CFU per day) or placebo every days
      for 28 days

      Weekly, each patient will be called twice to interrogate the number of events colic as well
      as the different variables under study

      After birth, on 15, 30, 45 and 60 of life will be cited for clinical examination and review
      and weight dropper bottle of probiotic

      • Principal: Number of events or inconsolable crying

      • Secondary: Average or evacuations / day Average or regurgitation / day Drugs to decrease
      excessive crying Medical reviews for excessive crying Changes feeding for excessive crying
      Level of satisfaction with the care of the newborn (numerical scale from 0: the worst
      possible, 10: completely satisfied)

      • Universal variables

      Weight:

      Size:

      Gender Weeks gestation Type of birth Feeding of formula / breast-
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Event number of colic</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">478</enrollment>
  <condition>Colic</condition>
  <arm_group>
    <arm_group_label>Lactobacillus reuteri group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lactobacillus reuteri DSM 17938 1,000,000,000 CFU per day (5 drops) for 28 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (5 drops) for 28 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus reuteri DSM 17938</intervention_name>
    <description>Lactobacillus reuteri DSM 17938 1,000,000,000 CFU per day (5 drops) for 28 days</description>
    <arm_group_label>Lactobacillus reuteri group</arm_group_label>
    <other_name>BioGaia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The placebo consisted of an identical bottle with distilled water</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Term Healthy Newborns (RN) ≥38 weeks and ≤ 41 weeks of gestation.

          -  Appropriate weight for gestational age

          -  ≥than 8 Apgar at 5 minutes

          -  Egress at the first 24-48 hours of life of the newborn with the mother of hospital

          -  No congenital or physical abnormalities on physical examination at birth.

          -  Availability during the study period.

          -  Thorough understanding of the protocol by parents

          -  Informed Consent is signed by both parents.

        Exclusion Criteria:

          -  Administration of antibiotics to the mother for a week before the birth of the
             newborn.

          -  Administration of probiotics newborn before inclusion or consumption by the mother
             during these last two trimesters.

          -  Medication Management newborn different routine prescribed at birth.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Week</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Héctor Javier Varona Bobadilla, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Secretaria de Marina-Armada de México (Mexican Navy)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Héctor Javier Varona Bobadilla, Dr.</last_name>
    <phone>(52) 55 56 24 65 00</phone>
    <phone_ext>5423</phone_ext>
    <email>kavel_555@hotmail.com</email>
  </overall_contact>
  <reference>
    <citation>Hyman PE, Milla PJ, Benninga MA, Davidson GP, Fleisher DF, Taminiau J. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology. 2006 Apr;130(5):1519-26. Review.</citation>
    <PMID>16678565</PMID>
  </reference>
  <reference>
    <citation>WESSEL MA, COBB JC, JACKSON EB, HARRIS GS Jr, DETWILER AC. Paroxysmal fussing in infancy, sometimes called colic. Pediatrics. 1954 Nov;14(5):421-35.</citation>
    <PMID>13214956</PMID>
  </reference>
  <reference>
    <citation>Douglas P, Hill P. Managing infants who cry excessively in the first few months of life. BMJ. 2011 Dec 15;343:d7772. doi: 10.1136/bmj.d7772. Review.</citation>
    <PMID>22174332</PMID>
  </reference>
  <reference>
    <citation>E. Ortega Páeza , D. Barroso Espaderob Flashes pediátricos AEpap Cólico del lactante Rev Pediatr Aten Primaria Supl. 2013;(22):81-7</citation>
  </reference>
  <reference>
    <citation>Wolke D, Samara M, Alvarez Wolke M. Meta-analysis of fuss/cry durations and colic prevalence across countries: Proceedings of the11th International Infant Cry Research Workshop, June, 2011, The Netherlands.</citation>
  </reference>
  <reference>
    <citation>Cohen GM, Albertini LW. Colic. Pediatr Rev. 2012 Jul;33(7):332-3; discussion 333. doi: 10.1542/pir.33-7-332.</citation>
    <PMID>22753793</PMID>
  </reference>
  <reference>
    <citation>Barr RG, Rotman A, Yaremko J, Leduc D, Francoeur TE. The crying of infants with colic: a controlled empirical description. Pediatrics. 1992 Jul;90(1 Pt 1):14-21.</citation>
    <PMID>1614771</PMID>
  </reference>
  <reference>
    <citation>Romanello S, Spiri D, Marcuzzi E, Zanin A, Boizeau P, Riviere S, Vizeneux A, Moretti R, Carbajal R, Mercier JC, Wood C, Zuccotti GV, Crichiutti G, Alberti C, Titomanlio L. Association between childhood migraine and history of infantile colic. JAMA. 2013 Apr 17;309(15):1607-12. doi: 10.1001/jama.2013.747.</citation>
    <PMID>23592105</PMID>
  </reference>
  <reference>
    <citation>Savino F, Cordisco L, Tarasco V, Calabrese R, Palumeri E, Matteuzzi D. Molecular identification of coliform bacteria from colicky breastfed infants. Acta Paediatr. 2009 Oct;98(10):1582-8. doi: 10.1111/j.1651-2227.2009.01419.x. Epub 2009 Jul 9.</citation>
    <PMID>19604166</PMID>
  </reference>
  <reference>
    <citation>de Weerth C, Fuentes S, Puylaert P, de Vos WM. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics. 2013 Feb;131(2):e550-8. doi: 10.1542/peds.2012-1449. Epub 2013 Jan 14.</citation>
    <PMID>23319531</PMID>
  </reference>
  <reference>
    <citation>Savino F, Cresi F, Pautasso S, Palumeri E, Tullio V, Roana J, Silvestro L, Oggero R. Intestinal microflora in breastfed colicky and non-colicky infants. Acta Paediatr. 2004 Jun;93(6):825-9.</citation>
    <PMID>15244234</PMID>
  </reference>
  <reference>
    <citation>Iacono G, Merolla R, D'Amico D, Bonci E, Cavataio F, Di Prima L, Scalici C, Indinnimeo L, Averna MR, Carroccio A; Paediatric Study Group on Gastrointestinal Symptoms in Infancy. Gastrointestinal symptoms in infancy: a population-based prospective study. Dig Liver Dis. 2005 Jun;37(6):432-8. Epub 2005 Mar 2.</citation>
    <PMID>15893282</PMID>
  </reference>
  <reference>
    <citation>Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006 Apr;130(5):1377-90. Review.</citation>
    <PMID>16678553</PMID>
  </reference>
  <reference>
    <citation>Charrois TL, Sandhu G, Vohra S. Probiotics. Pediatr Rev. 2006 Apr;27(4):137-9. Review.</citation>
    <PMID>16581954</PMID>
  </reference>
  <reference>
    <citation>http://www.biogaia.com/lactobacillus-reuter</citation>
  </reference>
  <reference>
    <citation>Talarico TL, Casas IA, Chung TC, Dobrogosz WJ. Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrob Agents Chemother. 1988 Dec;32(12):1854-8.</citation>
    <PMID>3245697</PMID>
  </reference>
  <reference>
    <citation>Morelli L, Capurso L. FAO/WHO guidelines on probiotics: 10 years later. J Clin Gastroenterol. 2012 Oct;46 Suppl:S1-2. doi: 10.1097/MCG.0b013e318269fdd5.</citation>
    <PMID>22955349</PMID>
  </reference>
  <reference>
    <citation>Lifschitz C. Probiotics: Implications for Paediatric Health, Nestlé Nutrition Institute, South Asia Workshop Proceedings Vol. 1, Issue 1, 2013</citation>
  </reference>
  <reference>
    <citation>Savino F, Pelle E, Palumeri E, Oggero R, Miniero R. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics. 2007 Jan;119(1):e124-30.</citation>
    <PMID>17200238</PMID>
  </reference>
  <reference>
    <citation>Savino F, Cordisco L, Tarasco V, Palumeri E, Calabrese R, Oggero R, Roos S, Matteuzzi D. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics. 2010 Sep;126(3):e526-33. doi: 10.1542/peds.2010-0433. Epub 2010 Aug 16.</citation>
    <PMID>20713478</PMID>
  </reference>
  <reference>
    <citation>Chumpitazi BP, Shulman RJ. Five probiotic drops a day to keep infantile colic away? JAMA Pediatr. 2014 Mar;168(3):204-5. doi: 10.1001/jamapediatrics.2013.5002.</citation>
    <PMID>24424486</PMID>
  </reference>
  <reference>
    <citation>Sung V, Collett S, de Gooyer T, Hiscock H, Tang M, Wake M. Probiotics to prevent or treat excessive infant crying: systematic review and meta-analysis. JAMA Pediatr. 2013 Dec;167(12):1150-7. doi: 10.1001/jamapediatrics.2013.2572. Review.</citation>
    <PMID>24100440</PMID>
  </reference>
  <reference>
    <citation>Indrio F, Di Mauro A, Riezzo G, Civardi E, Intini C, Corvaglia L, Ballardini E, Bisceglia M, Cinquetti M, Brazzoduro E, Del Vecchio A, Tafuri S, Francavilla R. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. JAMA Pediatr. 2014 Mar;168(3):228-33. doi: 10.1001/jamapediatrics.2013.4367.</citation>
    <PMID>24424513</PMID>
  </reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2015</study_first_submitted>
  <study_first_submitted_qc>October 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2015</study_first_posted>
  <last_update_submitted>October 15, 2015</last_update_submitted>
  <last_update_submitted_qc>October 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Naval de Alta Especialidad - Escuela Medico Naval</investigator_affiliation>
    <investigator_full_name>Dr. Jorge Ivan Valencia Moncada</investigator_full_name>
    <investigator_title>Prevention of colic with the probiotic Lactobacillus reuteri DSM 17938 in Mexican infants: randomized, double-blind study</investigator_title>
  </responsible_party>
  <keyword>colic</keyword>
  <keyword>probiotic</keyword>
  <keyword>Lactobacillus reuteri</keyword>
  <keyword>prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

